Clinical outcomes and longitudinal circulating tumor DNA changes after treatment with nivolumab and olaparib in immunotherapy relapsed melanoma with detected homologous recombination deficiency

The treatment of immunotherapy relapsed cutaneous melanoma constitutes a challenge in both research and clinical practice fields given the lack of effective therapeutic options. Homologous recombination deficiency (HRD) has been identified in several solid cancers including cutaneous melanoma. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales: Khaddour, Karam, Ansstas, Michael, Ansstas, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory Press 2021
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559618/
https://www.ncbi.nlm.nih.gov/pubmed/34667064
http://dx.doi.org/10.1101/mcs.a006129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559618/
https://www.ncbi.nlm.nih.gov/pubmed/34667064
http://dx.doi.org/10.1101/mcs.a006129

Ejemplares similares